BRCA2 and neoplasm: After lncRNA POU6F2‐AS2 knockdown, tumour shrinkage was observed, and the expression of cancer resistance‐related gene (P‐gp, MRP2 and BRCA2) was down‐regulated, indicating lncRNA POU6F2‐AS2 knockdown enhanced sensitivity of 5‐FU.